Read + Share
French JA, Cole AJ, Faught E, Theodore WH, et al. Safety and Efficacy of Nataluzimab as Adjunctive Therapy for People With
Drug-Resistant Epilepsy: A Phase 2 Study. Neurology 2021 Sep 14. pii: WNL.0000000000012766.
PMID: 34521687
|
 |
|
French JA, Cole AJ, Faught E, Theodore WH, et al. Safety and Efficacy of Nataluzimab as Adjunctive Therapy for People With
Drug-Resistant Epilepsy: A Phase 2 Study. Neurology 2021 Sep 14. pii: WNL.0000000000012766.
PMID: 34521687
|
|
|
|